4//SEC Filing
Werner Sean 4
Accession 0001628280-25-014180
CIK 0000834365other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:07 PM ET
Size
5.1 KB
Accession
0001628280-25-014180
Insider Transaction Report
Form 4
Werner Sean
Chief Technology Officer
Transactions
- Award
Common Stock
2025-03-18+22,919→ 27,784 total
Footnotes (1)
- [F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0002047541
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 7:07 PM ET
- Size
- 5.1 KB